Showing results (331-340 of 405) with videos related to

Sort By:
Pageof 41
Annals of Neurology|November 20, 2015
Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis riskZongqi Xia, Charles C White, Emily K Owen, et al.
Neurology|June 21, 2015
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M Wingerchuk, Brenda Banwell, Jeffrey L Bennett, et al.
Science Translational Medicine|September 10, 2025
Type I interferon limits central nervous system autoimmunity by modulating the microRNA-21-FOXO1 axis in pathogenic T helper 17 cellsJohnna Francis Varghese, Mai Fujiwara, Amrendra K Ajay, et al.
Journal of Child Neurology|September 16, 2025
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC RegistryMelissa A Wright, Bradley J Barney, Skyler Peterson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 9, 2024
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosisAmin Ziaei, Olivia Solomon, T Charles Casper, et al.
Annals of Clinical and Translational Neurology|December 20, 2018
Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosisTanuja Chitnis, Cindy Gonzalez, Brian C Healy, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 14, 2023
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccineSarah Conway, Shrishti Saxena, Clare Baecher-Allan, et al.
Npj Aging|June 5, 2026
Nasal administration of Protollin enhances monocyte phagocytosis and decreases CD8+ T cell cytotoxicity in subjects with early Alzheimer's disease: a Phase 1 clinical trialPanayota Kolypetri, Patrick da Silva, Ronaldo S Francisco, et al.
Neurology|December 9, 2021
Association Between Time Spent Outdoors and Risk of Multiple SclerosisPrince Sebastian, Nicolas Cherbuin, Lisa F Barcellos, et al.
Multiple Sclerosis and Related Disorders|March 5, 2023
Silent findings: Examination of asymptomatic demyelination in a pediatric US cohortVikram Bhise, Michael Waltz, T Charles Casper, et al.
Pageof 41